Business
ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive
About this update from Ani Pharmaceuticals, Inc.
[{"type":"text","content":" BAUDETTE, Minn.--(BUSINESS WIRE)--\nANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021 as follows:\n\n\n\nDate:\n\n\n\nMonday, November 22, 2021\n\n\n\n\n\nTime/On Demand:\n\n\n\n10:00 a.m. ET\n\n\n\n\nWebcast: https://pipersandler.zoom.us/rec/play/64bSMhpWNru89rAZwgbw_bbk5hNSzXKCBmCoMBP2qXNhF2h83k_wp6c7HmRongJQjr_nHxDjHPMgg4T6.4mLgs_b6Am4vVU6-\n\nThe webcast will be accessible on demand and archived for 90 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section.\n\nANI Pharmaceuticals will be participating in 1x1 meetings. Meetings can be requested exclusively via Piper Sandler.\n\nAbout ANI\n\nANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. For more information, please visit www.anipharmaceuticals.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211122005985/en/\n\nInvestor Relations:\nLisa M. Wilson, In-Site Communications, Inc.\nT: 212-452-2793\nE: [email protected]\n\nSource: ANI Pharmaceuticals, Inc.","length":4295,"tagName":"div"}]